Jasper Therapeutics, Inc. (JSPR) shares are trading higher on Wednesday morning trade. Oppenheimer today initiated coverage on Jasper Therapeutics with outperform rating. On September 24, the shares have touched a year-to-date. Thereafter the shares started to decline however started to spike yesterday.
Currently, shares are at $14.74, up 104.44 percent from the previous close of $7.21 on a volume of 9,465,985. For the 52-week period, the shares have traded in a range of $7.11-$15.80 on average volume of 437,901.
For comments and feedback contact: editorial@rttnews.com
Business News
December 26, 2025 08:42 ET Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.